Results 81 to 90 of about 316 (127)

A neglected symptom? Parietal gait lateropulsion as primary manifestation of acute is-chemic stroke. [PDF]

Rev Neurol, 2023
Castillo-Torres SA, Soto-Rincón CA, Gil-Valadez AH, Chávez-Luévanos BE, Góngora-Rivera F.   +4 more
europepmc   +1 more source

Botulinum toxin treatment in a resource-limited setting: Experiences from a public institution in a developing country [PDF]

Biomedica
Panesso GA, Martínez JD, Velasco A, Forero S, Perdomo D, Villamil Á, González ER, Jiménez CA.   +7 more
europepmc   +1 more source

Outcome of SARS-CoV-2 associated Guillain-Barre syndrome depends on early treatment and vaccination. [PDF]

Rev Neurol, 2022
Finsterer J, Scorza FA.
europepmc   +1 more source

A Rare Guillain-Barré Syndrome Variant with Multi-Ganglioside Reactivity: A Case of Severe Cranial Nerve Involvement. [PDF]

Rev Neurol
Gómez-Dabó L, Llaurado A, Sánchez-Tejerina D, González V, Montalvo-Olmedo C, Lázaro-Hernández C, Rodrigo-Gisbert M, López-Maza S, Iza-Achutegui M, Giramé-Rizzo L, Raguer N, Juntas R.   +11 more
europepmc   +1 more source

Miller Fisher syndrome treated with plasmapheresis during pregnancy: Case report and review of the literature [PDF]

Rev Colomb Obstet Ginecol, 2021
Ángel-Páez JA, Hurtado-Bugna S, Aragón-Mendoza RL, Altman-Restrepo M, Díaz-Yamal IJ, Centanaro-Meza GA.   +5 more
europepmc   +1 more source

[Relationship between severity of hypomimia and basic emotion recognition in Parkinson's disease]. [PDF]

Rev Neurol
Cossini F, Cuesta C, Román K, Zambrano S, Rubinstein W, Politis D.   +5 more
europepmc   +1 more source

[Miller-Fisher/Guillain-Barré overlap syndrome following COVID-19 vaccination]. [PDF]

Rev Med Inst Mex Seguro Soc
Atzin-Vela GA, Monroy-Parra CA, González-Rodríguez CH.   +2 more
europepmc   +1 more source

Variante no descrita previamente en el gen COL3A1: causalidad del Síndrome de Ehlers-Danlos tipo Vascular. [PDF]

Adv Lab Med
Gutiérrez Romero E, Padilla Apuntate N, Izquierdo Álvarez S.   +2 more
europepmc   +1 more source

Food borne-botulism during SARS-CoV-2 pandemic time. A case and a possible familial outbreak in Barcelona. [PDF]

Rev Neurol, 2022
Casado-Ruiz V, Cano A, Suárez-López A, Muriana D, Guanyabens-Buscà N, Sanz-Cartagena P, Álvarez-Larruy M, Palomeras E.   +7 more
europepmc   +1 more source

Efectos adversos inmunomediados por inhibidores de PD-1

Revista del Hospital Italiano de Buenos Aires
Los anticuerpos monoclonales que inhiben los puntos de control PD-1 y CTLA-4 se usan actualmente en el tratamiento del melanoma y cáncer metastásico de pulmón de células no pequeñas, entre otros.
María Paz Micieli Galeazzi, María Echeverría, Julia Riganti, Hernán Staiger, Gabriela Brana, Estefanía Juszkiewicz, Luciano Garavaglia, Luis Daniel Mazzuoccolo   +7 more
doaj